We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
95 hedge funds and large institutions have $170M invested in scPharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
368% more call options, than puts
Call options by funds: $721K | Put options by funds: $154K
300% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 6
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
67% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 21
40% more capital invested
Capital invested by funds: $121M → $170M (+$48.8M)
23% more funds holding
Funds holding: 77 → 95 (+18)
2.69% less ownership
Funds ownership: 77.16% → 74.46% (-2.7%)
Holders
95
Holders Change
+18
Holders Change %
+23.38%
% of All Funds
1.36%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
24
Increased
35
Reduced
21
Closed
6
Calls
$721K
Puts
$154K
Net Calls
+$567K
Net Calls Change
+$205K
Top Buyers
Top Sellers
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.54M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.01M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$952K |
| 4 |
Renaissance Technologies
New York
|
-$785K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$493K |
